{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T01:40:51Z","timestamp":1685756451865},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2010,8,28]],"date-time":"2010-08-28T00:00:00Z","timestamp":1282953600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s00393-010-0664-7","type":"journal-article","created":{"date-parts":[[2010,8,26]],"date-time":"2010-08-26T23:53:30Z","timestamp":1282866810000},"page":"719-737","source":"Crossref","is-referenced-by-count":4,"title":["Juvenile Arthritiden","Juvenile arthritides"],"prefix":"10.1007","volume":"69","author":[{"given":"G.","family":"Horneff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,8,28]]},"reference":[{"key":"664_CR1","first-page":"390","volume":"31","author":"Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P et al (2004) International League of Associations for Rheumatology: International League of Aassociations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390\u2013392","journal-title":"J Rheumatol"},{"key":"664_CR2","first-page":"418","volume":"27","author":"Mitchell","year":"2000","unstructured":"Mitchell LA, Tingle AJ, Grace M et al (2000) Rubella virus vaccine associated arthropathy in postpartum immunized women: influence of preimmunization serologic status on development of joint manifestations. J Rheumatol 27:418\u2013423","journal-title":"J Rheumatol"},{"key":"664_CR3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0049-0172(94)90076-0","volume":"24","author":"Anand","year":"1994","unstructured":"Anand AJ, Glatt AE (1994) Salmonella osteomyelitis and arthritis in sickle cell disease. Semin Arthritis Rheum 24:211\u2013221","journal-title":"Semin Arthritis Rheum"},{"key":"664_CR4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s001120100254","volume":"150","author":"Schmeling","year":"2002","unstructured":"Schmeling H, Hirsch W, Burdach S, Horneff G (2002) Pyogene Sakroiliitis. Monatsschr Kinderheilkd 150:193\u2013195","journal-title":"Monatsschr Kinderheilkd"},{"key":"664_CR5","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/archpedi.1987.04460080084034","volume":"141","author":"Barton","year":"1987","unstructured":"Barton LL, Dunle LM, Farooq HH (1987) Septic arthritis in childhood. Am J Dis Child 141:898\u2013900","journal-title":"Am J Dis Child"},{"key":"664_CR6","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/01.inf.0000091293.32187.7b","volume":"22","author":"Odio","year":"2003","unstructured":"Odio CM, Ramirez T, Arias G et al (2003) Double blind, randomised, placebo-controlled study of dexamethasone therapy for hematogenous septic arthritis in children. Pediatr Infect Dis J 22:883\u2013888","journal-title":"Pediatr Infect Dis J"},{"key":"664_CR7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM200107123450207","volume":"345","author":"Steere","year":"2001","unstructured":"Steere AC (2001) Lyme disease. N Engl J Med 345:115\u2013125","journal-title":"N Engl J Med"},{"key":"664_CR8","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/BF02072065","volume":"149","author":"Huppertz","year":"1990","unstructured":"Huppertz HI (1990) Childhood Lyme borreliosis in Europe. Eur J Pediatr 149:814\u2013821","journal-title":"Eur J Pediatr"},{"key":"664_CR9","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780380310","volume":"38","author":"Huppertz","year":"1995","unstructured":"Huppertz HI, Karch H, Suschke HJ et al (1995) Lyme arthritis in European children and adolescents. The Pediatric Rheumatology Collaborative Group. Arthritis Rheum 38:361\u2013368","journal-title":"Arthritis Rheum"},{"key":"664_CR10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1056\/NEJM200107123450201","volume":"345","author":"Nadelman","year":"2001","unstructured":"Nadelman RB, Nowakowski J, Fish D et al (2001) Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N Engl J Med 345:79\u201384","journal-title":"N Engl J Med"},{"key":"664_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/314053","volume":"31","author":"Wormser","year":"2000","unstructured":"Wormser GP, Nadelman RB, Dattwyler RJ et al (2000) Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America. Clin Infect Dis 31(Suppl 1):1\u201314","journal-title":"Clin Infect Dis"},{"key":"664_CR12","unstructured":"Deutsche Gesellschaft f\u00fcr P\u00e4diatrische Infektiologie (DGPI) e.V. (2009) 5., vollst. \u00fcberarb. und erw. Aufl."},{"key":"664_CR13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199807233390401","volume":"339","author":"Steere","year":"1998","unstructured":"Steere AC, Sikand VK, Meurice F et al (1998) Vaccination against Lyme disease with recombinat borrelia burgdorferi outer-surface lipoprotein a with adjuvant. N Engl J Med 339:209\u2013215","journal-title":"N Engl J Med"},{"key":"664_CR14","first-page":"1968","volume":"23","author":"Bowyer","year":"1996","unstructured":"Bowyer S, Roettcher P, members of the Pediatric Rheumatology Database Research Group (1996) Pediatric rheumatology clinic populations in the United States: results of a 3 year survey. J Rheumatol 23:1968\u20131974","journal-title":"J Rheumatol"},{"key":"664_CR15","first-page":"1831","volume":"23","author":"Malleson","year":"1996","unstructured":"Malleson PN, Fung MY, Rosenberg AM (1996) The incidence of pediatric rheumatic diseases: results from the Candian Pediatric Rheumatology Aassociation Disease Registry. J Rheumatol 23:1831\u20131837","journal-title":"J Rheumatol"},{"key":"664_CR16","first-page":"1975","volume":"23","author":"Symmons","year":"1996","unstructured":"Symmons DP, Jones M, Osborne J et al (1996) Juvenile rheumatoid arthritis in the United Kingdom: data from the British Pediatric Rheumatology Group National diagnostic Register. J Rheumatol 23:1975\u20131980","journal-title":"J Rheumatol"},{"key":"664_CR17","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1136\/ard.2005.045484","volume":"65","author":"Putschky","year":"2006","unstructured":"Putschky N, Pott HG, Kuipers JG et al (2006) Comparing 10-day and 4-month doxycycline courses for treatment of chlamydia trachomatis-reactive arthritis: a prospective, double-blind trial. Ann Rheum Dis 65:1521\u20131524","journal-title":"Ann Rheum Dis"},{"key":"664_CR18","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1084\/jem.172.1.359","volume":"172","author":"Tomai","year":"1990","unstructured":"Tomai M, Koth B, Majundar C, Beachey EA (1990) Superantigenicity of streptococcal M protein. J Exp Med 172:359\u2013362","journal-title":"J Exp Med"},{"key":"664_CR19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1084\/jem.169.1.269","volume":"169","author":"Bessen","year":"1989","unstructured":"Bessen D, Jones KF, Fischetti VA (1989) Evidence for two distinct classes of streptococcal M protein and their relationship to rheumatic fever. J Exp Med 169:269\u2013283","journal-title":"J Exp Med"},{"key":"664_CR20","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1172\/JCI112531","volume":"77","author":"Ayoub","year":"1986","unstructured":"Ayoub EM, Barret DJ, McLaren NK, Krischer JP (1986) Association of class II huiman histocompatibility leukocyte antigens with rheumatic fever. J Clin Invest 77:2019\u20132025","journal-title":"J Clin Invest"},{"key":"664_CR21","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1001\/jama.1992.03490150121036","volume":"268","author":"Dajani","year":"1992","unstructured":"Dajani AS and special writing group (1992) Guidelines for the diagnosis of rheumatic fever. Jones Criteria 1992 update. JAMA 268:2069\u20132073","journal-title":"JAMA"},{"key":"664_CR22","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2165\/00003495-199957040-00007","volume":"57","author":"Thatai","year":"1999","unstructured":"Thatai D, Turi ZG (1999) Current guidelines for the treatment of patients with rheumatic fever. Drugs 57:545\u2013555","journal-title":"Drugs"},{"key":"664_CR23","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/1531-8257(199909)14:5<805::AID-MDS1013>3.0.CO;2-P","volume":"14","author":"Cardoso","year":"1999","unstructured":"Cardoso F, Vargas AP, Oliveira LD et al (1999) Persistent Sydenham\u2019s chorea. Mov Disord 14:805\u2013807","journal-title":"Mov Disord"},{"key":"664_CR24","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1542\/peds.96.4.758","volume":"96","author":"Dajani","year":"1995","unstructured":"Dajani A, Taubert K, Ferrieri P et al (1995) Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Pediatrics 96:758\u2013764","journal-title":"Pediatrics"},{"key":"664_CR25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/archpedi.1984.02140420007003","volume":"138","author":"Majeed","year":"1984","unstructured":"Majeed HA, Shaltout A, Yousof AM (1984) Recurrence of acute rheumatic fever. Am J Dis Child 138:341\u2013345","journal-title":"Am J Dis Child"},{"key":"664_CR26","doi-asserted-by":"crossref","unstructured":"Mackie SL, Keat A (2004) Poststreptococcal reactive arthritis: what is it and how do we know? Rheumatology (Oxford) 43:949\u2013954","DOI":"10.1093\/rheumatology\/keh225"},{"key":"664_CR27","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/1529-0131(199806)41:6<1096::AID-ART17>3.0.CO;2-Y","volume":"41","author":"Ahmed","year":"1998","unstructured":"Ahmed S, Ayoub EM, Scornik JC et al (1998) Poststreptococcal reactive arthritis: clinical characteristics and association with HLA-DR alleles. Arthritis Rheum 41:1096\u20131102","journal-title":"Arthritis Rheum"},{"key":"664_CR28","first-page":"529","volume":"22","author":"Moon","year":"1995","unstructured":"Moon RY, Greene MG, Rehe GT, Katona IM (1995) Poststreptococcal reactive arthritis in children: a potential predecessor of rheumatic heart disease. J Rheumatol 22:529\u2013532","journal-title":"J Rheumatol"},{"key":"664_CR29","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1542\/peds.93.5.837","volume":"93","author":"Schaffer","year":"1994","unstructured":"Schaffer FM, Agarwal R, Helm J et al (1994) Poststreptococcal reactive arthritis and silent carditis: a case report and review of the literature. Pediatrics 93:837\u2013839","journal-title":"Pediatrics"},{"key":"664_CR30","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1002\/art.10444","volume":"46","author":"Minden","year":"2002","unstructured":"Minden K, Niewerth M, Listing J et al (2002) Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum 46:2392\u20132401","journal-title":"Arthritis Rheum"},{"key":"664_CR31","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/rheumatology\/38.8.739","volume":"38","author":"Petty","year":"1999","unstructured":"Petty RE (1999) Prognosis in children with rheumatic diseases: justification for consideration of new therapies. Rheumatology 38:739\u2013742","journal-title":"Rheumatology"},{"key":"664_CR32","first-page":"366","volume":"25","author":"Flat\u00f8","year":"1998","unstructured":"Flat\u00f8 B, Aasland A, Vinje O, F\u00f8rre O (1998) Outcome and predictive factors in juvenile rheumatoid arthritis and juvenile spondyloarthropathy. J Rheumatol 25:366\u2013375","journal-title":"J Rheumatol"},{"key":"664_CR33","first-page":"449","volume":"4","author":"Brunner","year":"2006","unstructured":"Brunner J, Sitzmann FC (2006) The diagnostic value of anti-cyclic citrullinated peptide (CCP) antibodies in children with juvenile idiopathic arthritis. Clin Exp Rheumatol 4:449\u2013451","journal-title":"Clin Exp Rheumatol"},{"key":"664_CR34","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/art.24823","volume":"61","author":"Magni-Manzoni","year":"2009","unstructured":"Magni-Manzoni S, Epis O, Ravelli A et al (2009) Comparison of clinical versus ultrasound-determined synovitis in juvenile idiopathic arthritis. Arthritis Rheum 61:1497\u2013504","journal-title":"Arthritis Rheum"},{"key":"664_CR35","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/art.22246","volume":"5","author":"Rossi","year":"2006","unstructured":"Rossi F, Di Dia F, Galipo O et al (2006) Use of the Sharp and Larsen scoring methods in the assessment of radiographic progression in juvenile idiopathic arthritis. Arthritis Rheum 5:717\u2013722","journal-title":"Arthritis Rheum"},{"key":"664_CR36","first-page":"1925","volume":"34","author":"Billiau","year":"2007","unstructured":"Billiau AD, Hu Y, Verdonck A et al (2007) Temporomandibular joint arthritis in juvenile idiopathic arthritis: prevalence, clinical and radiological signs, and relation to dentofacial morphology. J Rheumatol 34:1925\u20131933","journal-title":"J Rheumatol"},{"key":"664_CR37","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/art.21774","volume":"5","author":"Singh-Grewal","year":"2006","unstructured":"Singh-Grewal D, Schneider R, Bayer N, Feldman BM (2006) Predictors of disease course and remission in systemic juvenile idiopathic arthritis: significance of early clinical and laboratory features. Arthritis Rheum 5:1595\u20131601","journal-title":"Arthritis Rheum"},{"key":"664_CR38","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/art.24349","volume":"60","author":"Frosch","year":"2009","unstructured":"Frosch M, Ahlmann M, Vogl T et al (2009) The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1beta form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 60:883\u2013891","journal-title":"Arthritis Rheum"},{"key":"664_CR39","first-page":"823","volume":"34","author":"Lotito","year":"2007","unstructured":"Lotito AP, Campa A, Silva CA et al (2007) Interleukin 18 as a marker of disease activity and severity in patients with juvenile idiopathic arthritis. J Rheumatol 34:823\u2013830","journal-title":"J Rheumatol"},{"key":"664_CR40","doi-asserted-by":"crossref","unstructured":"Heiligenhaus A, Niewerth M, Ganser G et al (2007) German Uveitis in Childhood Study Group. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology (Oxford) 46(6):1015\u20131019","DOI":"10.1093\/rheumatology\/kem053"},{"key":"664_CR41","first-page":"131","volume":"27","author":"Horneff","year":"2009","unstructured":"Horneff G, Burgos-Vargas R (2009) Juvenile idiopathic arthritis. Subgroup characteristics and comparisons between rheumatoid arthritis-like subgroups and ankylosing spondylitis-like subgroups. Clin Exp Rheumatol 27(4 Suppl 55):131\u2013138","journal-title":"Clin Exp Rheumatol"},{"key":"664_CR42","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0022-3476(82)80747-6","volume":"100","author":"Shore","year":"1982","unstructured":"Shore A, Ansell BM (1982) Juvenile psoriatic arthritis \u2013 an analysis of 60 cases. J Pediatr 100:529\u2013535","journal-title":"J Pediatr"},{"key":"664_CR43","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3109\/03009748309099735","volume":"12","author":"Haapasaari","year":"1983","unstructured":"Haapasaari J, Wuolijoki E, Ylijoki H (1983) Treatment of juvenile rheumatoid arthritis with diclofenac sodium. Scand J Rheumatol 12:325\u2013330","journal-title":"Scand J Rheumatol"},{"key":"664_CR44","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0022-3476(05)80708-5","volume":"117","author":"Giannini","year":"1990","unstructured":"Giannini EH, Brewer EJ, Miller ML et al (1990) Ibuprofen suspension in the treatment of juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. J Pediatr 117:645\u2013652","journal-title":"J Pediatr"},{"key":"664_CR45","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3109\/03009748409111307","volume":"13","author":"Kvien","year":"1984","unstructured":"Kvien TK, Hoyeraal HM, Sandstad B (1984) Naproxen and acetylsalicylic acid in the treatment of pauciarticular and polyarticular juvenile rheumatoid arthritis. Assessment of tolerance and efficacy in a single-centre 24-week double-blind parallel study. Scand J Rheumatol 13:342\u2013350","journal-title":"Scand J Rheumatol"},{"key":"664_CR46","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/03009747709095449","volume":"6","author":"M\u00e4kel\u00e4","year":"1977","unstructured":"M\u00e4kel\u00e4 AL (1977) Naproxen in the treatment of juvenile rheumatoid arthritis. Metabolism, safety and efficacy. Scand J Rheumatol 6:193\u2013205","journal-title":"Scand J Rheumatol"},{"key":"664_CR47","first-page":"49","volume":"8","author":"Garcia-Morteo","year":"1987","unstructured":"Garcia-Morteo O, Maldonado-Cocco JA, Cuttica R, Garay SM (1987) Piroxicam in juvenile rheumatoid arthritis. Eur J Rheumatol Inflamm 8:49\u201353","journal-title":"Eur J Rheumatol Inflamm"},{"key":"664_CR48","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/art.20860","volume":"52","author":"Ruperto","year":"2005","unstructured":"Ruperto N, Nikishina I, Pachanov ED et al (2005) Pediatric Rheumatology International Trials Organization. A randomized, double-blind clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis: short- and long-term efficacy and safety results. Arthritis Rheum 52:563\u2013572","journal-title":"Arthritis Rheum"},{"key":"664_CR49","first-page":"985","volume":"33","author":"Reiff","year":"2006","unstructured":"Reiff A, Lovell DJ, Adelsberg JV et al (2006) Evaluation of the comparative efficacy and tolerability of rofecoxib and naproxen in children and adolescents with juvenile rheumatoid arthritis: a 12-week randomized controlled clinical trial with a 52-week open-label extension. J Rheumatol 33:985\u2013995","journal-title":"J Rheumatol"},{"key":"664_CR50","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3899\/jrheum.080073","volume":"36","author":"Foeldvari","year":"2009","unstructured":"Foeldvari I, Szer IS, Zemel LS et al (2009) A prospective study comparing celecoxib with naproxen in children with juvenile rheumatoid arthritis. J Rheumatol 36:174\u2013182","journal-title":"J Rheumatol"},{"key":"664_CR51","first-page":"511","volume":"105","author":"Zernikow","year":"2008","unstructured":"Zernikow B, Hechler T (2008) Schmerztherapie bei Kindern und Jugendlichen. Dtsch Arztebl 105:511\u2013522","journal-title":"Dtsch Arztebl"},{"key":"664_CR52","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1056\/NEJM198605153142001","volume":"314","author":"Brewer","year":"1986","unstructured":"Brewer EJ, Giannini EH, Kuzmina N, Alekseev L (1986) Penicillamine and hydroxychloroquine in the treatment of severe juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind placebo-controlled trial. N Engl J Med 314:1269\u20131276","journal-title":"N Engl J Med"},{"key":"664_CR53","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/art.1780330402","volume":"33","author":"Giannini","year":"1990","unstructured":"Giannini EH, Brewer EJ Jr, Kuzmina N et al (1990) Auranofin in the treatment of juvenile rheumatoid arthritis. Results of the USA-USSR double-blind, placebo-controlled trial. The USA Pediatric Rheumatology Collaborative Study Group. The USSR Cooperative Children\u2019s Study Group. Arthritis Rheum 33:466\u2013476","journal-title":"Arthritis Rheum"},{"key":"664_CR54","first-page":"118","volume":"13","author":"Kvien","year":"1986","unstructured":"Kvien TK, Hoyeraal HM, Sandstad B (1986) Azathioprine versus placebo in patients with juvenile rheumatoid arthritis: a single center double blind comparative study. J Rheumatol 13:118\u2013123","journal-title":"J Rheumatol"},{"key":"664_CR55","first-page":"599","volume":"5","author":"Ruperto","year":"2006","unstructured":"Ruperto N, Ravelli A, Castell E et al (2006) Cyclosporine A in juvenile idiopathic arthritis. Results of the PRCSG\/PRINTO phase IV post marketing surveillance study.Clin Exp Rheumatol 5:599\u2013605","journal-title":"Clin Exp Rheumatol"},{"key":"664_CR56","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1056\/NEJM199204163261602","volume":"326","author":"Giannini","year":"1992","unstructured":"Giannini EH, Brewer EJ, Kuzmina N et al (1992) Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children\u2019s Study Group. N Engl J Med 326:1043\u20131049","journal-title":"N Engl J Med"},{"key":"664_CR57","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/1529-0131(200008)43:8<1849::AID-ANR22>3.0.CO;2-F","volume":"43","author":"Woo","year":"2005","unstructured":"Woo P, Southwood TR, Prieur A et al (2005) Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis. Arthritis Rheum 43:1849\u20131857","journal-title":"Arthritis Rheum"},{"key":"664_CR58","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1002\/art.20288","volume":"50","author":"Ruperto","year":"2004","unstructured":"Ruperto N, Murray KJ, Gerloni V et al (2004) Pediatric Rheumatology International Trials Organization. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. Arthritis Rheum 50:2191\u20132201","journal-title":"Arthritis Rheum"},{"key":"664_CR59","unstructured":"Horneff G (2007) Wirksamkeit und Vertr\u00e4glichkeit der Therapie mit Methotrexat bei Patienten mit juveniler idiopathischer Arthritis \u2013 Analyse aus dem Deutschen Methotrexatregister. Tagung der Gesellschaft Kinder- und Jugendrheumatologie, Meerbusch"},{"key":"664_CR60","first-page":"480","volume":"25","author":"van","year":"2007","unstructured":"van der Meer A, Wulffraat NM, Prakken BJ et al (2007) Psychological side effects of MTX treatment in juvenile idiopathic arthritis: a pilot study. Clin Exp Rheumatol 25:480\u2013485","journal-title":"Clin Exp Rheumatol"},{"key":"664_CR61","first-page":"201","volume":"9","author":"Ansell","year":"1991","unstructured":"Ansell BM, Hall MA, Loftus JK et al (1991) A multicentre pilot study of sulphasalazine in juvenile chronic arthritis. Clin Exp Rheumatol 9:201\u2013203","journal-title":"Clin Exp Rheumatol"},{"key":"664_CR62","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/1529-0131(199805)41:5<808::AID-ART6>3.0.CO;2-T","volume":"41","author":"Van","year":"1998","unstructured":"Van Rossum MA, Fiselier TJ, Franssen MJ et al (1998) Sulfasalzin in the treatment of juvenile chronic arthritis. A randomized double-blind placebo-controlled multicenter study. Arthritis Rheum 41:808\u2013816","journal-title":"Arthritis Rheum"},{"key":"664_CR63","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1136\/ard.61.10.941","volume":"61","author":"Burgos-Vargas","year":"2002","unstructured":"Burgos-Vargas R, Vazquez-Mellado J, Pacheco-Tena C et al (2002) A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies. Ann Rheum Dis 61:941\u2013942","journal-title":"Ann Rheum Dis"},{"key":"664_CR64","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMoa041810","volume":"352","author":"Silverman","year":"2005","unstructured":"Silverman E, Mouy R, Spiegel L et al (2005) Leflunomide in Juvenile Rheumatoid Arthritis (JRA) Investigator Group. Leflunomide or methotrexate for juvenile rheumatoid arthritis. N Engl J Med 352:1655\u20131666","journal-title":"N Engl J Med"},{"key":"664_CR65","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/1529-0131(199707)40:7<1202::AID-ART3>3.0.CO;2-R","volume":"40","author":"Giannini","year":"1997","unstructured":"Giannini EH, Ruperto N, Raveli A et al (1997) Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 40:1202\u20131209","journal-title":"Arthritis Rheum"},{"key":"664_CR66","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJM200003163421103","volume":"342","author":"Lovell","year":"2000","unstructured":"Lovell DJ, Giannini EH, Reiff A Cawkwell GD et al (2000) Etanercept in children with polyarticular juvenile rheumatoid arthritis. N Engl J Med 342:763\u2013769","journal-title":"N Engl J Med"},{"key":"664_CR67","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/art.10885","volume":"48","author":"Quartier","year":"2003","unstructured":"Quartier P, Taupin P, Bourdeaut F et al (2003) Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis Rheum 48:1093\u20131101","journal-title":"Arthritis Rheum"},{"key":"664_CR68","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1136\/ard.2003.014886","volume":"63","author":"Horneff","year":"2004","unstructured":"Horneff G, Schmeling H, Biedermann T et al (2004) The German Etanercept Registry for treatment of juvenile idiopathic arthritis (JIA). Ann Rheum Dis 63:1638\u20131644","journal-title":"Ann Rheum Dis"},{"key":"664_CR69","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00112-005-1128-z","volume":"153","author":"Horneff","year":"2005","unstructured":"Horneff G (2005) Einsatz von Biologika bei der juvenilen idiopathischen Arthritis. Konsensusstatement des 7. W\u00f6rlitzer Expertengespr\u00e4ches 2004 f\u00fcr die Arbeitsgemeinschaft Kinder- und Jugendrheumatologie. Monatsschr Kinderheilkd 153:473\u2013479","journal-title":"Monatsschr Kinderheilkd"},{"key":"664_CR70","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/art.21885","volume":"54","author":"Lovell","year":"2006","unstructured":"Lovell DJ, Reiff A, Jones OY et al (2006) Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum 54:1987\u20131994","journal-title":"Arthritis Rheum"},{"key":"664_CR71","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/art.23427","volume":"58","author":"Lovell","year":"2008","unstructured":"Lovell DJ, Reiff A, Ilowite NT et al (2008) Pediatric Rheumatology Collaborative Study Group. Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis. Arthritis Rheum 58:1496\u20131504","journal-title":"Arthritis Rheum"},{"key":"664_CR72","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1136\/ard.2007.087593","volume":"68","author":"Horneff","year":"2009","unstructured":"Horneff G, De Bock F, Foeldvari I et al (2009) Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA). Preliminary data from the German JIA Registry. Ann Rheum Dis 68:519\u2013525","journal-title":"Ann Rheum Dis"},{"key":"664_CR73","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00296-007-0399-1","volume":"28","author":"Kuemmerle-Deschner","year":"2007","unstructured":"Kuemmerle-Deschner JB, Horneff G (2007) Safety and efficacy of once-weekly application of etanercept in children with juvenile idiopathic arthritis. Rheumatol Int 28:153\u2013156","journal-title":"Rheumatol Int"},{"key":"664_CR74","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/ard.2006.067629","volume":"66","author":"Prince","year":"2007","unstructured":"Prince FH, Twilt M, Jansen-Wijngaarden NC, Suijlekom-Smit LW van (2007) Effectiveness of a once weekly double dose of etanercept in patients with juvenile idiopathic arthritis: a clinical study. Ann Rheum Dis 66:704\u2013705","journal-title":"Ann Rheum Dis"},{"key":"664_CR75","doi-asserted-by":"crossref","unstructured":"Horneff G, Ebert A, Fitter S et al (2009) Safety and efficacy of once weekly etanercept 0.8\u00a0mg\/kg in a multicentre 12 week trial in active polyarticular course juvenile idiopathic arthritis. Rheumatology (Oxford) 48:916\u2013919","DOI":"10.1093\/rheumatology\/kep122"},{"key":"664_CR76","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa0706290","volume":"359","author":"Lovell","year":"2008","unstructured":"Lovell DJ, Ruperto N, Goodman S et al (2008) Pediatric Rheumatology Collaborative Study Group; Pediatric Rheumatology International Trials organisation. Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. N Engl J Med 359:810\u2013820","journal-title":"N Engl J Med"},{"key":"664_CR77","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1002\/art.22838","volume":"56","author":"Ruperto","year":"2007","unstructured":"Ruperto N, Lovell DJ, Cuttica R et al (2007) Paediatric Rheumatology International Trials Organisation; Pediatric Rheumatology Collaborative Study Group: a randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum 56:3096\u20133106","journal-title":"Arthritis Rheum"},{"key":"664_CR78","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/ard.2009.100354","volume":"69","author":"Ruperto","year":"2010","unstructured":"Ruperto N, Lovell DJ, Cuttica R et al (2010) Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis: findings from an open-label treatment extension. Ann Rheum Dis 69:718\u2013722","journal-title":"Ann Rheum Dis"},{"key":"664_CR79","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10067-008-0995-9","volume":"28","author":"Ilowite","year":"2009","unstructured":"Ilowite N, Porras O, Reiff A et al (2009) Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study. Clin Rheumatol 28:129\u2013137","journal-title":"Clin Rheumatol"},{"key":"664_CR80","first-page":"S632","volume":"58","author":"Quartier","year":"2008","unstructured":"Quartier P, Allantaz F, Cimaz R et al (2008) A multicentric, double-blind trial of Anakinra versus placebo in Systemic-Onset Juvenile Idiopathic Arthritis (ANAJIS trial): efficacy and tolerance over 12 month. Ann Rheum Dis 58:S632","journal-title":"Ann Rheum Dis"},{"key":"664_CR81","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/art.21556","volume":"54","author":"Lovell","year":"2006","unstructured":"Lovell DJ, Gianinni EH, Kimura Y et al (2006) Prelimonary evidence for bioactivity of IL-1 trap (Rilonacept), a long acting il-1 inhibitor, in systemic juvenile idiopathic arthritis (sJIA). Arthritis Rheum 54:325","journal-title":"Arthritis Rheum"},{"key":"664_CR82","doi-asserted-by":"crossref","first-page":"S2055","DOI":"10.1002\/art.24616","volume":"60","author":"Ruperto","year":"2009","unstructured":"Ruperto N, Quartier P, Wulfraat N et al for PRINTO (2009) Evaluation of safety and preliminary efficacy of canakinumab (ACZ885), a new IL-1-beta blocking monoclonal antibody, in children with systemic juvenile idiopathic arthritis (sJIA). Arthritis Rheum 60:S2055","journal-title":"Arthritis Rheum"},{"key":"664_CR83","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(08)60454-7","volume":"371","author":"Yokota","year":"2008","unstructured":"Yokota S, Imagawa T, Mori M et al (2008) Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial. Lancet 371:998\u20131006","journal-title":"Lancet"},{"key":"664_CR84","first-page":"326","volume":"54","author":"Lovell","year":"2006","unstructured":"Lovell DJ, Ruperto N, Prieur AM et al (2006) Assessment of open label co-stimulation blockade with abatacept in children and adolescents with active juvenile idiopathic arthritis (JIA). Arthritis Rheum 54:326","journal-title":"Arthritis Rheum"},{"key":"664_CR85","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/art.21565","volume":"54","author":"Giannini","year":"2006","unstructured":"Giannini EH, Ruperto N, Prieur AM et al (2006) Efficacy and safety of abatacept in children and adolescents with active juvenile idiopathic arthritis (JIA): results of double-blind withdrawal phase. 2006 Annual Scientific Meeting of the American College of Rheumatology, October 16\u201321, Washington, USA. Arthritis Rheum 54:482","journal-title":"Arthritis Rheum"},{"key":"664_CR86","first-page":"2290","volume":"31","author":"Wallace","year":"2004","unstructured":"Wallace CA, Ruperto N, Giannini E (2004) Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol 31:2290\u20132294","journal-title":"J Rheumatol"},{"key":"664_CR87","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0022-3476(95)70320-9","volume":"127","author":"Huppertz","year":"1995","unstructured":"Huppertz HI, Tschammler A, Horwitz AE, Schwab KO (1995) Intraarticular corticosteroids for chronic arthritis in children: effciacy and effects on cartilage and growth. J Pediatr 127:317\u2013321","journal-title":"J Pediatr"},{"key":"664_CR88","doi-asserted-by":"crossref","unstructured":"Zulian F, Martini G, Gobber D et al (2004) Triamcinolone acetonide and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: a double-blind trial. Rheumatology (Oxford) 43:1288\u20131291","DOI":"10.1093\/rheumatology\/keh313"},{"key":"664_CR89","unstructured":"Beukelman T, Guevara JP, Albert DA (2007) Outcome in the initial treatment of knee monoarthritis in JIA: results of a decision analysis model. Arthritis Rheum (54 Suppl)"},{"key":"664_CR90","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1177\/112067210701700509","volume":"17","author":"Heiligenhaus","year":"2007","unstructured":"Heiligenhaus A, Mingels A, Heinz C, Ganser G (2007) Methotrexate for uveitis associated with juvenile idiopathic arthritis: value and requirement for additional anti-inflammatory medication. Eur J Ophthalmol 17(5):743\u2013748","journal-title":"Eur J Ophthalmol"},{"key":"664_CR91","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1002\/art.22709","volume":"56","author":"Saurenmann","year":"2007","unstructured":"Saurenmann RK, Rose JB, Tyrrell P et al (2007) Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factor. Arthritis Rheum 56:1974\u20131984","journal-title":"Arthritis Rheum"},{"key":"664_CR92","doi-asserted-by":"crossref","unstructured":"Saurenmann RK, Levin AV, Feldman BM et al (2010) Risk factors for development of uveitis differ between girls and boys with juvenile idiopathic arthritis. Arthritis Rheum [Epub ahead of print]","DOI":"10.1002\/art.27416"},{"key":"664_CR93","first-page":"1146","volume":"34","author":"Foeldvari","year":"2007","unstructured":"Foeldvari I, Nielsen S, K\u00fcmmerle-Deschner J et al (2007) Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey. J Rheumatol 34:1146\u20131150","journal-title":"J Rheumatol"},{"key":"664_CR94","doi-asserted-by":"crossref","unstructured":"Simonini G, Zannin ME, Caputo R et al (2008) Loss of efficacy during long-term infliximab therapy for sight-threatening childhood uveitis. Rheumatology (Oxford) 47:1510\u20131514","DOI":"10.1093\/rheumatology\/ken298"},{"key":"664_CR95","doi-asserted-by":"crossref","unstructured":"Tynj\u00e4l\u00e4 P, Kotaniemi K, Lindahl P et al (2008) Adalimumab in juvenile idiopathic arthritis-associated chronic anterior uveitis. Rheumatology (Oxford) 47:339\u2013344","DOI":"10.1093\/rheumatology\/kem356"},{"key":"664_CR96","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/bjo.2006.103721","volume":"91","author":"Biester","year":"2007","unstructured":"Biester S, Deuter C, Michels H et al (2007) Adalimumab in the therapy of uveitis in childhood. Br J Ophthalmol 91:319\u2013324","journal-title":"Br J Ophthalmol"},{"key":"664_CR97","first-page":"655","volume":"15","author":"Bennett","year":"1988","unstructured":"Bennett AE, Silverman ED, Miller JJ et al (1988) Insulin-like-growth-factor-1 and -2 in children with systemic onset juvenile arthritis. J Rheumatol 15:655\u2013658","journal-title":"J Rheumatol"},{"key":"664_CR98","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/art.1780400218","volume":"40","author":"Davis","year":"1997","unstructured":"Davis UM, Jones J, Reeve J et al (1997) Juvenile rheumatoid arthritis. Effects of disease activity and recombinant human growth hormone on insulin-like growth factor 1, insulin-like growth factor binding proteins 1 and 3, and osteocalcin. Arhritis Rheum 40:332\u2013340","journal-title":"Arhritis Rheum"},{"key":"664_CR99","unstructured":"Horneff G (2004) Wachstumsst\u00f6rungen bei chronisch-entz\u00fcndlichen Erkrankungen: Juvenile idiopathische Arthritis. In: Ranke MB, Sch\u00f6nau E (Hrsg) Wachstumsst\u00f6rungen im Kindes- und Jugendalter aus der Perspektive des Knochens. Verlag Wissenschaftliche Scripten, Zwickau, S 109\u2013116"},{"key":"664_CR100","first-page":"779","volume":"21","author":"Schmeling","year":"2003","unstructured":"Schmeling H, Seliger E, Horneff G (2003) Growth reconstitution in juvenile idiopathic arthritis treated with etanercept. Clin Exp Rheumatol 21:779\u2013784","journal-title":"Clin Exp Rheumatol"},{"key":"664_CR101","first-page":"80","volume":"52","author":"Zak","year":"1999","unstructured":"Zak M et al (1999) Final height, armspan, subischial leg length and body proportions in juvenile chronic arthritis. Horm Res 52:80\u201385","journal-title":"Horm Res"},{"key":"664_CR102","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1210\/jc.2006-2877","volume":"92","author":"Simon","year":"2007","unstructured":"Simon D, Prieur AM, Quartier P et al (2007) Early recombinant human growth hormone treatment in glucocorticoid-treated children with juvenile idiopathic arthritis: a 3-year randomized study. J Clin Endocrinol Metab 92:2567\u20132573","journal-title":"J Clin Endocrinol Metab"},{"key":"664_CR103","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1210\/jc.2007-0544","volume":"92","author":"Bechtold","year":"2007","unstructured":"Bechtold S, Ripperger P, Dalla Pozza R et al (2007) Growth hormone increases final height in patients with juvenile idiopathic arthritis: data from a randomized controlled study. J Clin Endocrinol Metab 92:3013\u20133018","journal-title":"J Clin Endocrinol Metab"},{"key":"664_CR104","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1002\/art.22118","volume":"9","author":"Okuda","year":"2006","unstructured":"Okuda Y, Takasugi K (2006) Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis. Arthritis Rheum 9:2997\u20133000","journal-title":"Arthritis Rheum"},{"key":"664_CR105","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1136\/ard.2005.048835","volume":"8","author":"Burnham","year":"2006","unstructured":"Burnham JM, Shults J, Weinstein R et al (2006) Childhood onset arthritis is associated with an increased risk of fracture: a population based study using the General Practice Research Database. Ann Rheum Dis 8:1074\u20131079","journal-title":"Ann Rheum Dis"},{"key":"664_CR106","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/ard.54.3.193","volume":"54","author":"Polito","year":"1995","unstructured":"Polito C, Strano CG, Rea L et al (1995) Reduced bone mineral content and normal serum osteocalcin in non-steroid-treated patients with juvenile rheumatoid arthritis. Ann Rheum Dis 54:193\u2013196","journal-title":"Ann Rheum Dis"},{"key":"664_CR107","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1002\/art.21956","volume":"53","author":"Lovell","year":"2006","unstructured":"Lovell DJ, Glass D, Ranz J et al (2006) A randomized controlled trial of calcium supplementation to increase bone mineral density in children with juvenile rheumatoid arthritis. Arthritis Rheum 53:2235\u20132242","journal-title":"Arthritis Rheum"},{"key":"664_CR108","doi-asserted-by":"crossref","unstructured":"Vastert SJ, Wijk R van, D\u2019Urbano LE et al (2010) Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis. Rheumatology (Oxford) 49:441\u2013449]","DOI":"10.1093\/rheumatology\/kep418"},{"key":"664_CR109","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/ncprheum0919","volume":"4","author":"Kelly","year":"2008","unstructured":"Kelly A, Ramanan AV (2008) A case of macrophage activation syndrome successfully treated with anakinra. Nat Clin Pract Rheumatol 4:615\u2013620","journal-title":"Nat Clin Pract Rheumatol"},{"key":"664_CR110","unstructured":"Bruck N, J Hamel, Suttorp M et al (2009) Remission of Macrophage Activation Syndrome (MAS) associated with systemic-onset juvenile idiopathic arthritis by treatment with anakinra but without cyclosporine. ACR Abstract 234"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-010-0664-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-010-0664-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-010-0664-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T01:03:14Z","timestamp":1685754194000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-010-0664-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,28]]},"references-count":110,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["664"],"URL":"https:\/\/doi.org\/10.1007\/s00393-010-0664-7","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,28]]}}}